Last reviewed · How we verify
Blood samples for Hematology
Blood samples for Hematology is a Biologic drug developed by Groupe Francais De Pneumo-Cancerologie. It is currently in Phase 2 development for Blood sample collection and analysis for hematology tests.
This drug is used to analyze blood samples for hematology.
This drug is used to analyze blood samples for hematology. Used for Blood sample collection and analysis for hematology tests.
At a glance
| Generic name | Blood samples for Hematology |
|---|---|
| Sponsor | Groupe Francais De Pneumo-Cancerologie |
| Modality | Biologic |
| Therapeutic area | Hematology |
| Phase | Phase 2 |
Mechanism of action
The drug is used to collect and analyze blood samples for various hematology tests, including complete blood counts and blood chemistry tests.
Approved indications
- Blood sample collection and analysis for hematology tests
Common side effects
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors (PHASE1, PHASE2)
- Bevacizumab In Hereditary Hemorrhagic Telangiectasia (PHASE2)
- Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE) (NA)
- Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 (PHASE3)
- Lung Cancer Prevention Screening Programme in Italy (NA)
- Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion (EARLY_PHASE1)
- PBMC as Biomarkers of Diabetic Cardiomyopathy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood samples for Hematology CI brief — competitive landscape report
- Blood samples for Hematology updates RSS · CI watch RSS
- Groupe Francais De Pneumo-Cancerologie portfolio CI
Frequently asked questions about Blood samples for Hematology
What is Blood samples for Hematology?
How does Blood samples for Hematology work?
What is Blood samples for Hematology used for?
Who makes Blood samples for Hematology?
What development phase is Blood samples for Hematology in?
Related
- Manufacturer: Groupe Francais De Pneumo-Cancerologie — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Blood sample collection and analysis for hematology tests
- Compare: Blood samples for Hematology vs similar drugs
- Pricing: Blood samples for Hematology cost, discount & access